Relay Therapeutics Inc RLAY:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 10:31 AM EDT
6.58quote price arrow down-0.16 (-2.30%)
Volume
140,822
52 week range
5.70 - 13.32
Loading...
  • Open6.65
  • Day High6.65
  • Day Low6.50
  • Prev Close6.74
  • 52 Week High13.32
  • 52 Week High Date07/12/23
  • 52 Week Low5.70
  • 52 Week Low Date04/24/24

Key Stats

  • Market Cap874.104M
  • Shares Out132.74M
  • 10 Day Average Volume1.11M
  • Dividend-
  • Dividend Yield-
  • Beta1.68
  • YTD % Change-40.15

KEY STATS

  • Open6.65
  • Day High6.65
  • Day Low6.50
  • Prev Close6.74
  • 52 Week High13.32
  • 52 Week High Date07/12/23
  • 52 Week Low5.70
  • 52 Week Low Date04/24/24
  • Market Cap874.104M
  • Shares Out132.74M
  • 10 Day Average Volume1.11M
  • Dividend-
  • Dividend Yield-
  • Beta1.68
  • YTD % Change-40.15

RATIOS/PROFITABILITY

  • EPS (TTM)-2.64
  • P/E (TTM)-2.50
  • Fwd P/E (NTM)-2.27
  • EBITDA (TTM)-356.688M
  • ROE (TTM)-40.40%
  • Revenue (TTM)35.327M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-931.64%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/06/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Relay Therapeutics Inc

 

Profile

MORE
Relay Therapeutics Inc. is a clinical-stage precision medicine company. The Company is focused on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The Company’s Dynamo platform integrates an array of computational and experimental approaches designed to drug protein targets that have previously been intractable or inadequately addressed. The Company’s lead product candidates, such as RLY-2608, Lirafugratinib (RLY-4008), and...
Alexis Borisy
Independent Chairman of the Board
Sanjiv Patel M.D.
President, Chief Executive Officer, Director
Thomas Catinazzo
Chief Financial Officer
Address
399 Binney Street, 2Nd Floor
Cambridge, MA
02139
United States

Top Peers

SYMBOLLASTCHG%CHG
IMTX
Immatics NV
10.72UNCHUNCH
IMNM
Immunome Inc
15.66+0.33+2.19%
TNGX
Tango Therapeutics Inc
7.56-0.29-3.69%
ZNTL
Zentalis Pharmaceuticals Inc
12.09-0.22-1.76%
LQDA
Liquidia Corp
12.45-0.39-3.03%